Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	182.14	162.89	128	115.78	181.79	202.22
Depreciation & Amortization	58.67	59.83	63.41	74.19	92.71	94.32
Other Amortization	1.01	1.09	1.4	1.52	1.39	1.35
Asset Writedown & Restructuring Costs	-	-	-	17.78	6	-
Loss (Gain) From Sale of Investments	-15.61	-14.98	-4.23	3.96	29.48	-31.7
Stock-Based Compensation	-	-	-	-	-	1.59
Provision & Write-off of Bad Debts	-3.08	14.32	0.05	1.82	-	-3.5
Other Operating Activities	5.59	-9.32	-11.24	10.85	-45.74	33.62
Change in Accounts Receivable	-49.12	-88.39	-58.6	188.87	-1.38	-160.77
Change in Inventory	35.64	90.52	67.61	-17.96	-116.67	-136.05
Change in Accounts Payable	-2.21	-4.34	67.96	-96.22	-59.51	99.31
Change in Unearned Revenue	-19.34	-51.05	51.68	-22.45	-64.02	50.45
Change in Other Net Operating Assets	14.75	-0.47	22.64	-47.74	2.56	29.02
Operating Cash Flow	208.43	160.12	328.67	230.39	26.62	179.87
Operating Cash Flow Growth	-23.28%	-51.28%	42.66%	765.61%	-85.20%	-35.90%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-20.5	-15.26	-28.24	-21.91	-36.58	-26.59
Sale (Purchase) of Intangibles	-3.16	-4	-1.39	-3.07	-4.07	-3.6
Investment in Securities	9.8	9.8	-	-	-0.7	-2
Other Investing Activities	1.07	3.92	-5.96	2.48	-0.01	-2.83
Investing Cash Flow	-12.8	-5.54	-35.6	-22.5	-41.37	-35.02

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	18.27	29.45	281.16	964.61	1,690
Total Debt Issued	12.74	18.27	29.45	281.16	964.61	1,690
Short-Term Debt Repaid	-	-18.27	-59.45	-301.16	-1,065	-1,540
Long-Term Debt Repaid	-	-8.72	-8.7	-8.2	-7.68	-404.2
Total Debt Repaid	-21.5	-26.98	-68.15	-309.35	-1,072	-1,944
Net Debt Issued (Repaid)	-8.76	-8.72	-38.7	-28.2	-107.68	-254.2
Issuance of Common Stock	-	-	-	-	-	12.25
Common Dividends Paid	-119.94	-119.94	-109.95	-139.93	-129.94	-109.32
Other Financing Activities	-	-	-0.03	-0.02	0.01	-0.01
Financing Cash Flow	-128.7	-128.66	-148.67	-168.14	-237.6	-351.27

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	0.41	8.49	6.24	10.59	28.72	-25.19
Net Cash Flow	67.34	34.41	150.64	50.34	-223.63	-231.61

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	187.93	144.86	300.43	208.48	-9.97	153.28
Free Cash Flow Growth	-22.29%	-51.78%	44.10%	-	-	-34.87%
Free Cash Flow Margin	9.86%	7.45%	16.22%	12.44%	-0.44%	7.19%
Free Cash Flow Per Share	1.87	1.44	2.99	2.08	-0.10	1.45
Levered Free Cash Flow	137.03	98.15	254.23	164.39	-78.18	55.06
Unlevered Free Cash Flow	139.11	100.27	256.51	167.14	-74.81	62.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	3.34	3.39	3.64	4.39	5.4	4.7
Cash Income Tax Paid	21.71	21.77	48.43	18.9	24.04	9.19
Change in Working Capital	-20.28	-53.73	151.29	4.5	-239.01	-118.04

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error